Efficacy of enoximone in the management of refractory low-output states following cardiac surgery
- 1 August 1988
- journal article
- Published by Elsevier in Journal of Cardiothoracic Anesthesia
- Vol. 2 (4) , 409-418
- https://doi.org/10.1016/0888-6296(88)90220-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Pharmacology of enoximoneThe American Journal of Cardiology, 1987
- Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failureThe American Journal of Cardiology, 1987
- New Positive Inotropic Agents in the Treatment of Congestive Heart FailureNew England Journal of Medicine, 1986
- Inotropic Drugs for the Treatment of Heart FailureThe Journal of Clinical Pharmacology, 1985
- Amrinone in the management of low cardiac output after open heart surgeryThe American Journal of Cardiology, 1985
- Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL-17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failureAmerican Heart Journal, 1985
- Intravenous and oral MDL 17043 (A new inotrope-vasodilator agent) in congestive heart failure: Hemodynamic and clinical evaluation in 38 patientsJournal of the American College of Cardiology, 1984
- Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performanceThe American Journal of Cardiology, 1984
- Characterization of the Cardiovascular Activities of a New Cardiotonic Agent, MDL 17043 (1,3-Dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one)Journal of Cardiovascular Pharmacology, 1982
- Cardiovascular Properties of a New Cardiotonic AgentJournal of Cardiovascular Pharmacology, 1982